Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001971213-25-000085 0001971213 XXXXXXXX LIVE 3 Class A Common Stock, par value $0.01 per share 11/26/2025 false 0000832428 811054402 The E.W. Scripps Company 312 WALNUT STREET CINCINNATI OH 45202 Narinder K. Sahai 410-568-1500 c/o Sinclair, Inc. 10706 Beaver Dam Road Hunt Valley MD 21030 0001971213 N Sinclair, Inc. b WC N MD 7625401.00 0.00 7625401.00 0.00 7625401.00 N 9.9 CO The percent of class beneficially owned by the Reporting Person was calculated based on 76,869,408 shares of Class A Common Stock, par value $0.01 per share, outstanding as of September 30, 2025, as disclosed in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025. Class A Common Stock, par value $0.01 per share The E.W. Scripps Company 312 WALNUT STREET CINCINNATI OH 45202 This Amendment No. 3 ("Amendment No. 3") further amends and supplements the Schedule 13D initially filed on November 17, 2025, as amended by Amendment No. 1 filed on November 19, 2025, and by Amendment No. 2 filed on November 24, 2025. Item 4 is amended to include the following: Sinclair, Inc. (the "Reporting Person") notes that, on November 26, 2025, The E.W. Scripps Company (the "Issuer") announced the adoption of a shareholder rights plan, commonly known as a "poison pill". The Reporting Person believes that the strategic and financial rationale of a potential business combination with the Issuer is indisputable. Given the family control of the Issuer, the only effect of adopting a poison pill is to limit liquidity opportunities available for public shareholders of the Issuer. As requested by the Issuer, the Reporting Person submitted a proposal building upon prior constructive discussions between the parties. The Reporting Person intends to continue to engage with the Issuer in an effort to reach a mutually agreeable transaction that will deliver significant benefits to the Issuer's shareholders and local communities. Sinclair, Inc. Narinder K. Sahai Narinder K. Sahai/Chief Financial Officer 11/26/2025